HDAC9 and digestive system disorder: All three HDAC inhibitors exhibited common ADRs, including Thrombocytopenia, Decreased Neutrophil Count, Decreased Platelet Count, Investigations, General Disorders and Administration Site Conditions, as well as Gastrointestinal Disorders.